Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Mastocytosis, Systemic × avapritinib × Clear all

Phase

Phase 2 2 Phase 4 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Mastocytosis, Systemic 1 Gastrointestinal Stromal Tumors 1

Interventions

avapritinib 1 Imatinib Mesylate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06748001 2026-02-09

Avapritinib Rollover Study

Blueprint Medicines Corporation

Phase 4 Recruiting

Mastocytosis, Systemic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡